Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Jerome

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Psychopharmacology|August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Expert Review of Clinical Pharmacology|June 2, 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatmentsKyle T Greenway, Nicolas Garel, Lisa Jerome, et al.
Frontiers in Psychiatry|June 5, 2023
Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting systemTigran Makunts, Diane Dahill, Lisa Jerome, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Biological Psychiatry|December 28, 2017
Response to the Consensus Statement of the PTSD Psychopharmacology Working GroupAllison A Feduccia, Michael C Mithoefer, Lisa Jerome, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Journal of Traumatic Stress|June 11, 2021
Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress DisorderLinnae Ponte, Lisa Jerome, Scott Hamilton, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2022
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trialTerence Hw Ching, Monnica T Williams, Julie B Wang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Psychopharmacology|August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Expert Review of Clinical Pharmacology|June 2, 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatmentsKyle T Greenway, Nicolas Garel, Lisa Jerome, et al.
Frontiers in Psychiatry|June 5, 2023
Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting systemTigran Makunts, Diane Dahill, Lisa Jerome, et al.
Human Psychopharmacology|March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"Rick Doblin, George Greer, Julie Holland, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2010
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyMichael C Mithoefer, Mark T Wagner, Ann T Mithoefer, et al.
Biological Psychiatry|December 28, 2017
Response to the Consensus Statement of the PTSD Psychopharmacology Working GroupAllison A Feduccia, Michael C Mithoefer, Lisa Jerome, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Journal of Traumatic Stress|June 11, 2021
Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress DisorderLinnae Ponte, Lisa Jerome, Scott Hamilton, et al.
Journal of Psychopharmacology (Oxford, England)|June 21, 2022
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trialTerence Hw Ching, Monnica T Williams, Julie B Wang, et al.
Pageof 4